191 related articles for article (PubMed ID: 21432593)
1. The mixed amphetamine salt extended release (Adderall XR, Max-XR) as an adjunctive to SSRIS or SNRIS in the treatment of adult ADHD patients with comorbid partially responsive generalized anxiety: an open-label study.
Gabriel A
Atten Defic Hyperact Disord; 2010 Jun; 2(2):87-92. PubMed ID: 21432593
[TBL] [Abstract][Full Text] [Related]
2. Adjunctive atomoxetine to SSRIs or SNRIs in the treatment of adult ADHD patients with comorbid partially responsive generalized anxiety (GA): an open-label study.
Gabriel A; Violato C
Atten Defic Hyperact Disord; 2011 Dec; 3(4):319-26. PubMed ID: 21833565
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
4. An open-label study of the tolerability of mixed amphetamine salts in adults with attention-deficit/hyperactivity disorder and treated primary essential hypertension.
Wilens TE; Zusman RM; Hammerness PG; Podolski A; Whitley J; Spencer TJ; Gignac M; Biederman J
J Clin Psychiatry; 2006 May; 67(5):696-702. PubMed ID: 16841618
[TBL] [Abstract][Full Text] [Related]
5. A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder.
Biederman J; Wigal SB; Spencer TJ; McGough JJ; Mays DA
Clin Ther; 2006 Feb; 28(2):280-93. PubMed ID: 16678649
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.
Spencer TJ; Abikoff HB; Connor DF; Biederman J; Pliszka SR; Boellner S; Read SC; Pratt R
Clin Ther; 2006 Mar; 28(3):402-18. PubMed ID: 16750455
[TBL] [Abstract][Full Text] [Related]
7. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in patients with generalized anxiety disorder and a history of inadequate treatment response: a randomized, double-blind study.
Khan A; Atkinson S; Mezhebovsky I; She F; Leathers T; Pathak S
Ann Clin Psychiatry; 2013 Nov; 25(4):E7-22. PubMed ID: 24199224
[TBL] [Abstract][Full Text] [Related]
8. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in patients with generalized anxiety disorder and a history of inadequate treatment response: a randomized, double-blind study.
Khan A; Atkinson S; Mezhebovsky I; She F; Leathers T; Pathak S
Ann Clin Psychiatry; 2014 Feb; 26(1):3-18. PubMed ID: 24660224
[TBL] [Abstract][Full Text] [Related]
9. Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial.
Weisler RH; Biederman J; Spencer TJ; Wilens TE; Faraone SV; Chrisman AK; Read SC; Tulloch SJ
CNS Spectr; 2006 Aug; 11(8):625-39. PubMed ID: 16871129
[TBL] [Abstract][Full Text] [Related]
10. The extended-release formulation of quetiapine fumarate (quetiapine XR) adjunctive treatment in partially responsive generalized anxiety disorder (GAD): An open label naturalistic study.
Gabriel A
Clin Ter; 2011; 162(2):113-8. PubMed ID: 21533316
[TBL] [Abstract][Full Text] [Related]
11. A community assessment, open-label study of the safety, tolerability, and effectiveness of mixed amphetamine salts extended release in school-age children with ADHD.
Ambrosini PJ; Sallee FR; Lopez FA; Shi L; Michaels MA;
Curr Med Res Opin; 2006 Feb; 22(2):427-40. PubMed ID: 16466615
[TBL] [Abstract][Full Text] [Related]
12. Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial.
Levin FR; Mariani JJ; Specker S; Mooney M; Mahony A; Brooks DJ; Babb D; Bai Y; Eberly LE; Nunes EV; Grabowski J
JAMA Psychiatry; 2015 Jun; 72(6):593-602. PubMed ID: 25887096
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder.
Silverstone PH; Salinas E
J Clin Psychiatry; 2001 Jul; 62(7):523-9. PubMed ID: 11488362
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of triple-bead mixed amphetamine salts compared with a dose-augmentation strategy of mixed amphetamine salts extended release plus mixed amphetamine salts immediate release.
Ermer JC; Shojaei A; Pennick M; Anderson CS; Silverberg A; Youcha SH
Curr Med Res Opin; 2007 May; 23(5):1067-75. PubMed ID: 17519073
[TBL] [Abstract][Full Text] [Related]
15. Safety, efficacy and extended duration of action of mixed amphetamine salts extended-release capsules for the treatment of ADHD.
Weisler RH
Expert Opin Pharmacother; 2005 Jun; 6(6):1003-18. PubMed ID: 15952928
[TBL] [Abstract][Full Text] [Related]
16. An interim analysis of the Quality of Life, Effectiveness, Safety, and Tolerability (QU.E.S.T.) evaluation of mixed amphetamine salts extended release in adults with ADHD.
Goodman DW; Ginsberg L; Weisler RH; Cutler AJ; Hodgkins P
CNS Spectr; 2005 Dec; 10(12 Suppl 20):26-34. PubMed ID: 16344838
[TBL] [Abstract][Full Text] [Related]
17. Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD.
McGough JJ; Biederman J; Wigal SB; Lopez FA; McCracken JT; Spencer T; Zhang Y; Tulloch SJ
J Am Acad Child Adolesc Psychiatry; 2005 Jun; 44(6):530-8. PubMed ID: 15908835
[TBL] [Abstract][Full Text] [Related]
18. Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in children.
Findling RL; Biederman J; Wilens TE; Spencer TJ; McGough JJ; Lopez FA; Tulloch SJ;
J Pediatr; 2005 Sep; 147(3):348-54. PubMed ID: 16182674
[TBL] [Abstract][Full Text] [Related]
19. Forecasting three-month outcomes in a laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children With ADHD.
Faraone SV; Wigal SB; Hodgkins P
J Atten Disord; 2007 Jul; 11(1):74-82. PubMed ID: 17606774
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder.
Spencer T; Biederman J; Wilens T; Faraone S; Prince J; Gerard K; Doyle R; Parekh A; Kagan J; Bearman SK
Arch Gen Psychiatry; 2001 Aug; 58(8):775-82. PubMed ID: 11483144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
